These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M; Zarling JM J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243 [TBL] [Abstract][Full Text] [Related]
6. Human newborn autologous mixed lymphocyte response: frequency and phenotype of responders and xenoantigen specificity. Hayward AR; Mori M J Immunol; 1984 Aug; 133(2):719-23. PubMed ID: 6203976 [TBL] [Abstract][Full Text] [Related]
7. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051 [TBL] [Abstract][Full Text] [Related]
8. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination. Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433 [TBL] [Abstract][Full Text] [Related]
9. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus. Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis. Milikan JC; Kuijpers RW; Baarsma GS; Osterhaus AD; Verjans GM Exp Eye Res; 2006 Jul; 83(1):69-75. PubMed ID: 16530754 [TBL] [Abstract][Full Text] [Related]
12. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group. Haahr S; Møller-Larsen A; Pedersen E Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564 [TBL] [Abstract][Full Text] [Related]
13. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity. Kohl S; Loo LS J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968 [TBL] [Abstract][Full Text] [Related]
14. Immunity to herpes simplex virus in children receiving treatment for acute lymphoblastic leukaemia (ALL). Tellez PA; Odom L; Hayward AR Clin Exp Immunol; 1985 Dec; 62(3):525-9. PubMed ID: 3002690 [TBL] [Abstract][Full Text] [Related]
15. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. Asanuma H; Sharp M; Maecker HT; Maino VC; Arvin AM J Infect Dis; 2000 Mar; 181(3):859-66. PubMed ID: 10720505 [TBL] [Abstract][Full Text] [Related]